The Cholesterol Injection Just Became a Pill
Picture the patient you see every week. Fifty-eight, already on the highest statin dose she can tolerate, and her LDL still won’t budge…
The FDA Is Deciding Right Now Whether to Legitimize 7 Wildly Popular Peptides and the Outcome Reshapes Compounding Pharmacy
This week, in a meeting room at FDA’s White Oak campus in Silver Spring, Maryland, one of the most consequential compounding pharmacy…
The Intervention That Outlasted Its Own Intensity: What 21 Years of Follow-Up Just Taught Us About Prediabetes
Picture a 51-year-old walking into a clinic in 1998. Prediabetes. Slightly overweight. The kind of patient who sits across from you every…
CMS Just Launched a 10-Year Model That Pays for Outcomes, Not Visits and Pharmacists Are Explicitly Built Into It
On July 5, 2026, the Centers for Medicare and Medicaid Services quietly launched one of the most consequential innovation models in recent…
The Pill That Replaced the PICC Line
She’s 58 and has been through this before. Not the infection (though that too) recurring with the particular cruelty of UTIs in older…